Professor Georgina Long AO, BSc (Hons1, UM) PhD MBBS (Hons) FRACP FAHMS FAA, is the Co-Medical Director of Melanoma Institute Australia (MIA) and Chair of Melanoma Medical Oncology and Translational Research at MIA, Royal North Shore Hospital, and The University of Sydney. She leads a world-class clinical trials team and laboratory focusing on targeted therapies and immuno-oncology for melanoma. Professor Long serves as the principal investigator on pivotal phase I, II, and III trials, including groundbreaking studies in patients with active brain metastases.

A sought-after keynote speaker at prestigious global congresses, Professor Long also advises the biotechnology industry on drug development, helping to drive innovation in cancer treatment. She was named 2024 Australian of the Year, elected Fellow of the Australian Academy of Science (2024) and Health and Medical Sciences (2017), and appointed an Officer of the Order of Australia (2020). Other recent accolades include the Fulbright U.S. Mission Australia Award for Leadership excellence (2024), ESMO Women for Oncology Award (2023), and the Ramaciotti Medal for Biomedical Research (2021).